PYPD Latest Press Releases

-- September 15, 2026 --

PolyPid Announces Participation in Upcoming Fall Investor Conferences Globe Newswire 8:30 AM

-- August 12, 2026 --

PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results Globe Newswire 7:30 AM

-- July 30, 2026 --

PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026 Globe Newswire 8:00 AM

-- July 29, 2026 --

PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX100 Globe Newswire 8:30 AM

-- July 21, 2026 --

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX100 in the U.S. and Canada Globe Newswire 7:30 AM

-- June 1, 2026 --

PolyPid Completes New Drug Application Submission to FDA for D-PLEX100 Globe Newswire 8:30 AM

-- May 20, 2026 --

PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference Globe Newswire 8:30 AM

-- May 13, 2026 --

PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results Globe Newswire 7:30 AM

-- May 6, 2026 --

PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026 Globe Newswire 8:00 AM

-- April 28, 2026 --

PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software